A new trading day began on Monday, with Gossamer Bio Inc (NASDAQ: GOSS) stock price up 10.33% from the previous day of trading, before settling in for the closing price of $2.71. GOSS’s price has ranged from $0.66 to $3.60 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 40.29%. Meanwhile, its annual earnings per share averaged -180.00%. With a float of $184.81 million, this company’s outstanding shares have now reached $231.31 million.
Gossamer Bio Inc (GOSS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 20.15%, while institutional ownership is 63.29%. The most recent insider transaction that took place on Aug 19 ’25, was worth 50,016. In this transaction Director of this company bought 26,050 shares at a rate of $1.92, taking the stock ownership to the 58,050 shares.
Gossamer Bio Inc (GOSS) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.15 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -180.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.81% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Here are Gossamer Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Looking closely at Gossamer Bio Inc (NASDAQ: GOSS), its last 5-days average volume was 3.42 million, which is a jump from its year-to-date volume of 2.47 million. As of the previous 9 days, the stock’s Stochastic %D was 80.71%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 74.64%, which indicates a significant decrease from 91.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.62, while its 200-day Moving Average is $1.71. However, in the short run, Gossamer Bio Inc’s stock first resistance to watch stands at $3.15. Second resistance stands at $3.31. The third major resistance level sits at $3.55. If the price goes on to break the first support level at $2.74, it is likely to go to the next support level at $2.50. Should the price break the second support level, the third support level stands at $2.34.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
With a market capitalization of 692.06 million, the company has a total of 231,456K Shares Outstanding. Currently, annual sales are 114,700 K while annual income is -56,530 K. The company’s previous quarter sales were 13,290 K while its latest quarter income was -48,220 K.
